MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 7.16 USD 2.58% Market Closed
Market Cap: 1.1B USD

Relative Value

The Relative Value of one MDXG stock under the Base Case scenario is hidden USD. Compared to the current market price of 7.16 USD, MiMedx Group Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXG Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
69
Median 3Y
2.9
Median 5Y
2.9
Industry
7.9
Forward
2.6
vs History
15
vs Industry
6
Median 3Y
16.6
Median 5Y
-12
Industry
23.7
Forward
16.7
vs History
34
vs Industry
10
Median 3Y
16.9
Median 5Y
-21.1
Industry
22
vs History
31
vs Industry
5
Median 3Y
16.8
Median 5Y
-20
Industry
23.8
vs History
92
vs Industry
16
Median 3Y
6
Median 5Y
6.4
Industry
3.3
vs History
61
vs Industry
61
Median 3Y
2.6
Median 5Y
2.6
Industry
8.3
Forward
2.2
vs History
60
vs Industry
61
Median 3Y
3.2
Median 5Y
3.2
Industry
10.1
vs History
68
vs Industry
7
Median 3Y
17.1
Median 5Y
18.4
Industry
6.4
Forward
9
vs History
58
vs Industry
7
Median 3Y
18.7
Median 5Y
19
Industry
7
Forward
14.5
vs History
36
vs Industry
11
Median 3Y
15.5
Median 5Y
-19.5
Industry
8.3
vs History
36
vs Industry
8
Median 3Y
15.8
Median 5Y
-18
Industry
6.5
vs History
63
vs Industry
24
Median 3Y
6.2
Median 5Y
6.4
Industry
5.7

Multiples Across Competitors

MDXG Competitors Multiples
MiMedx Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MiMedx Group Inc
NASDAQ:MDXG
1.1B USD 2.7 26 14.1 17.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 790 068.7 -160 599.2 -195 018.6 -192 793.2
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
149.5B USD 5.1 18.4 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.9 -532 -579.3 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD 5.5 17 16.2 18.3
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
46.1B EUR 15 35.3 61 62.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.4 154.9 187.9
P/E Multiple
Earnings Growth PEG
US
MiMedx Group Inc
NASDAQ:MDXG
Average P/E: 169
26
17%
1.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 599.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
9%
1.9
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.3
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.4
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBITDA: 36.5
14.1
27%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 018.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
61
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
154.9
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MiMedx Group Inc
NASDAQ:MDXG
Average EV/EBIT: 42.2
17.3
18%
1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 793.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
62.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
187.9
N/A N/A